Department of General Medicine, Shirakawa Satellite for Teaching and Research (STAR), Fukushima Medical University, Shirakawa City, Fukushima, Japan; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima City, Fukushima, Japan.
Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima City, Fukushima, Japan; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima City, Fukushima, Japan; Center for Innovative Research for Communities and Clinical Excellence (CIRC(2)LE), Fukushima Medical University, Fukushima City, Fukushima, Japan.
Clin Nutr. 2022 Oct;41(10):2219-2225. doi: 10.1016/j.clnu.2022.07.037. Epub 2022 Aug 10.
BACKGROUND & AIMS: Aspiration pneumonia (AP) is a public health concern among older adults. Previous studies have reported the association between oral intake initiation within 48 h after hospital admission and better in-hospital outcomes among patients with AP. We investigated the association between initiation of oral intake within 24 h and in-hospital outcomes of older patients with AP undergoing dysphagia rehabilitation.
This retrospective cohort study was conducted from April 2015 to September 2020. Door-to-oral time (D2O) was defined as the time from hospital arrival to the first oral intake and was divided into early (within 24 h), middle (between 24 and 48 h), and late (over 48 h). We examined the associations between D2O and in-hospital outcomes: discharge with oral intake (by logistic regression analysis), length of stay, and days from the first oral intake to discharge (by fitting the general linear models with robust variance estimation).
Among the 398 patients with AP, 142 (35.7%) were classified into early, 111 (27.9%) into middle, and 145 (36.4%) into late groups. Compared with the late group, we found insufficient evidence that early D2O was associated with a greater likelihood of discharge with oral intake (adjusted odds ratio = 1.09; 95% confidence interval [95% CI]: 0.50 to 2.38). The early group was associated with a shorter length of stay (adjusted length difference [aLD] = -7.14 days; 95% CI: -10.80 to -3.42) but not with shorter days from first oral intake to discharge (aLD = -3.34 days; 95% CI: -6.91 to 0.24).
While D2O within 24 h among patients with AP was not associated with a decreased likelihood of discharge with oral intake, it was associated with a shorter length of stay. To improve outcomes without compromising the quality of AP care, early oral intake should be decided based on careful swallowing function assessment.
吸入性肺炎(AP)是老年人面临的公共卫生问题。既往研究报道,AP 患者入院后 48 小时内开始口服摄入与住院期间结局改善相关。本研究旨在探讨吞咽障碍康复治疗的 AP 老年患者在 24 小时内开始口服摄入与住院期间结局的关系。
本回顾性队列研究于 2015 年 4 月至 2020 年 9 月进行。经口进食时间(D2O)定义为从入院到首次经口摄入的时间,分为早期(24 小时内)、中期(24-48 小时之间)和晚期(超过 48 小时)。我们通过逻辑回归分析评估 D2O 与住院结局(经口进食出院)、住院时间和从首次经口摄入到出院的天数之间的关系。
398 例 AP 患者中,142 例(35.7%)为早期,111 例(27.9%)为中期,145 例(36.4%)为晚期。与晚期组相比,我们没有充分的证据表明早期 D2O 与更高的经口进食出院可能性相关(调整后比值比=1.09;95%置信区间[95%CI]:0.50 至 2.38)。早期组的住院时间更短(调整后长度差异[aLD]=-7.14 天;95%CI:-10.80 至-3.42),但从首次经口摄入到出院的天数没有差异(aLD=-3.34 天;95%CI:-6.91 至 0.24)。
AP 患者在 24 小时内开始经口摄入与经口进食出院的可能性降低无关,但与住院时间缩短有关。为了在不影响 AP 治疗质量的情况下改善结局,应基于仔细的吞咽功能评估来决定早期经口摄入。